이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

수면 뇌파, 수술 중 뇌파 및 수술 후 인지 기능 장애의 관계 (SOMEDYSPO)

2026년 9월 17일 업데이트: Assistance Publique - Hôpitaux de Paris

The challenge of new recommendations and better adapted practices is pushing to operate patients who are getting older and more fragile. In this context, there is an inevitable increase in the risks associated with care and in particular perioperative neurological complications, of which postoperative cognitive dysfunction (POCD) is the most common.

The interest of perioperative cerebral monitoring and in particular electroencephalography (EEG) to reduce neurological and cognitive damage in surgery has been the subject of abundant research and corresponds to a crucial issue.

From the literature and preliminary results obtained in our clinical research unit, it appears that there is also a relationship between certain characteristics of the peroperative EEG (signal strength and burst suppression) and the occurrence of postoperative cognitive dysfunction (PCOD).

In this context, quantitative analysis of the preoperative sleep EEG and the EEG obtained during general anesthesia could allow the identification of a simple to use biomarker of susceptibility or fragility. To our knowledge, there is no preoperative evaluation strategy using EEG analysis to detect a predisposition to POCD.

The main goal of this observational clinical study is to extend the traditional use of per-operative EEG with pre-operative and post-operative sleep EEG for the detection and prediction of early post-operative cognitive dysfunction.

연구 개요

상세 설명

The interest of perioperative brain monitoring to reduce neurological and cognitive damage in surgery has been the subject of much research and corresponds to a crucial issue.

The notion of quantitative EEG covers all the electrical signal processing techniques (fast Fourier transformation, evoked potentials, EEG mapping, etc.) made possible through the digitization of EEG data and the development of software to process these signals. In this context, EEG-derived indices have been set up to monitor hypnosis during general anesthesia. Between 0 (deep hypnosis) and 100 (awakening), the Bispectral Index (BIS) integrates in its calculation the percentage of fast waves, the degree of wave synchronization and the periods of EEG suppression (or "Burst suppression") and allows an adaptation of the dosage of anesthetic products according to its value.

Avoiding too deep anesthesia through neuro-monitoring could help to reduce postoperative delirium by reducing the burst suppression pattern.

Pre-operative cognitive status assessment :

The investigators observe a great delay in the means implemented to have an objective evaluation of cognitive disorders in preoperative care.

One of the pitfalls of our anesthetist specialty is the lack of continuity of medical care in the perioperative period.

The geriatric evaluation including a MMSE (mental mini state examination) and a MoCA (Montreal cognitive assessment) is performed only occasionally.

Interest of the resting pre-operative EEG :

Sleep EEG analysis is already used in cognitive studies. Slow Wave Activity (SWA) is a parameter known to be inversely correlated with chronological age and lowered more significantly in the context of cognitive dysfunction.

The power of spindles or sleep spindles and particularly fast spindles have been shown to be potentially predictive of poor cognitive development in patients already showing symptoms (Mild Cognitive Impairment).

It is likely that per operative susceptibility to Burst suppression and the appearance of postoperative cognitive dysfunction are linked to a set of per operative factors (anesthesia, surgery, inflammation, pain...) but also preoperative factors (cognitive state, physiological age and cerebral fragility...).

The investigators hypothesize that there is an association between preoperative resting EEG abnormalities and the risk of postoperative cognitive dysfunction.

The goal of this observational clinical study is to assess the fragility of a patient under general anesthesia and based on the perioperative quantitative analysis EEG. Thus, this project should help specialists in perioperative medicine to identify patients at risk of cognitive dysfunction and could lead to proposing strategies for its prevention.

Measures are based on neuro-psychological tests (Montreal cognitive assesment -MoCA) and EEG signal and subfrequency power spectral densities including alpha band as well as the amount of Propofol, each measured for EEG periods where SEF 95 = 8-13Hz.

Analysis includes the characteristics of the preoperative sleep EEG (SWA, fast spindles).

Experimental design: This is a single-center, observational prospective study.

Population concerned :

Patients eligible for interventional neuroradiology or surgery performed under General Anesthesia are selected to participate in this prospective, observational, single-center, routine care study. Patients will be included if they received, for a non-urgent scheduled procedure.

Patients over 18 years of age are eligible to participate in this protocol. During the anesthesia consultation, they will be given a hand-delivered letter of information on the objectives and the course of the study. Their non-opposition to participating in this study will be collected at the latest during the pre-anesthetic visit, on the eve of the operation after a period of reflection.

The protocol will start the day before the intervention. The interventions will be performed under general anaesthesia. The protocol does not interact with the care procedure. All the measures are obtained non-invasively.

The day before the procedure: performance of a sleep EEG (DREEM®) and a MoCA test. On the day of the procedure, monitoring of the depth of anesthesia using the quantitative EEG (Sedline Masimo®) ensures continuous recording of intraoperative EEG data. Postoperatively the same investigator performs MoCA at Day1, Day2 and Day5. A sleep EEG (DREEM®) is performed at Day2 and Day5 if the patient is still hospitalized.

During their general anesthesia, all patients' routine monitoring will consist in collecting the following parameters: electrocardiogram, pulsated oxygen saturation, endtidal CO2, respiratory rate, tidal volume and neuromuscular function.

For all patients whatever the comorbidities, anesthesia induction will be performed using a target-controlled infusion (Orchestra® Base Primea - Fresenius Kabi France).

No additional additional examination will be performed. The anesthetic strategy is decided by the anesthetist in charge of the procedure.

The doctor in charge of the study collecting the data does not interfere at any time in the management of the patient. The measurements cannot influence the prescribing physician since at this stage the data are not yet analysed and available.

Number of selected subjects: Assuming an incidence of DCPO of 30%, with power at 80% and alpha risk at 5%, it is necessary to include 100 patients to demonstrate an area under the ROC curve of 80% with a confidence interval width of 0.1

Statistics:

Continuous data will be expressed in median [interquartile] and qualitative data in n (%). Categorical variables will be compared by Mann-Whitney test and continuous variables by Wilcoxon test.

In this study, the primary endpoint was the occurrence of post-operative cognitive dysfunction, defined as a decrease in MoCA score of more than 4 points between preoperative and postoperative periods (worst value of the score measured at D1, D2 and D5). The main exposure is the quantitative score obtained from the analysis of the pre-operative sleep EEG.

The ability of the various parameters of interest of the preoperative sleep EEG to predict the occurrence of DCPO will be estimated by constructing an ROC curve. The area of these ROC curves will be measured and the corresponding 95% confidence interval estimated. The areas under the ROC curve of the different parameters will be compared by DeLong test. A uni- and then multivariate analysis will be performed to identify the clinical parameters associated with the occurrence of a DCPO. The possible added value of the sleep EEG parameters on the clinical parameters will be evaluated by reclassification techniques.

The statistical analysis will be carried out using the statistical analysis software "R" (The R Foundation, Vienna, Austria)

연구 유형

관찰

등록 (실제)

66

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Paris, 프랑스, 75010
        • AP-HP, Lariboisière Hospital, Department of Anesthesiology and Intensive Care

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

18년 이상 (성인, 고령자)

건강한 자원 봉사자를 받아들입니다

아니

연구 대상 성별

모두

샘플링 방법

확률 샘플

연구 인구

Patients eligible for a non-emergency scheduled interventional neuroradiology procedure or surgery performed under general anesthesia.

설명

Inclusion Criteria:

  • Major patients (≥ 18 years )
  • Eligible for an interventional radiology procedure or surgery under general anesthesia
  • Patients informed and having expressed their non-opposition to participation in this research

Exclusion Criteria:

  • Patients under 18 years old
  • Severe pre-existing cognitive impairment (preoperative mini-mental state examination (MMSE) < 24)
  • Patient opposed to protocol participation
  • Pregnant woman
  • Patient under judicial protection
  • Patient without affiliation to a social security scheme
  • Emergency procedure

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 관찰 모델: COHORT
  • 시간 관점: PROSPECTIVE

코호트 및 개입

그룹/코호트
개입 / 치료
Patients undergoing general anesthesia

Patients eligible for interventional neuroradiology or surgery performed under general anesthesia. Patients will be included if they are admitted for a non-emergency scheduled procedure.

Sleep EEG recording using a Dreem® headband (Rythm, Paris, France), an EEG recording device adapted to sleep conditions and completely non-invasive

Neuropsychological assessment using the The Montreal Cognitive Assessment (MoCA) questionnaire to detect postoperative cognitive dysfunction

Intraoperative brain function monitoring using a Sedline® module (Masimo corporation) to evaluate the state of the brain under anesthesia

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
Early postoperative cognitive dysfunction
기간: Change between day -1 and day 5

Score obtained following evaluation of the patient's cognitive function using the Montreal Cognitive Assessment questionnaire MoCA (0-30; higher score indicates better performance)

Change between day -1 and day 5

2차 결과 측정

결과 측정
측정값 설명
기간
Burst suppression duration
기간: Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)

For all patients the values of Burst Suppression (in % of time) will be collected from frontal electrodes montage (Fp1, Fp2, F7, F8) during the total anesthesia period (induction and hypnotic periods)

Duration of the surgical intervention or interventional neuroradiology procedure (maximum 1 day)
Variations in alpha power on sleep EEG
기간: Change between day -1 and day 5

Variations in alpha power (in Decibel, Db) on the pre-operative and post-operative sleep EEG

Change between day -1 and day 5
Spindle amplitude on sleep EEG
기간: Change between day -1 and day 5

Spindle amplitude (in Decibel, Db) on preoperative and postoperative sleep EEG

Change between day -1 and day 5
Spindle frequency on sleep EEG
기간: Change between day -1 and day 5

Spindle frequency (in Hertz, Hz) on preoperative and postoperative sleep EEG

Change between day -1 and day 5

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 연구 책임자: Joaquim MATEO, MD, Assistance Publique - Hôpitaux de Paris
  • 수석 연구원: Fabrice VALLEE, MD, Assistance Publique - Hôpitaux de Paris

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2020년 7월 15일

기본 완료 (실제)

2022년 2월 21일

연구 완료 (실제)

2022년 2월 21일

연구 등록 날짜

최초 제출

2020년 6월 23일

QC 기준을 충족하는 최초 제출

2020년 7월 17일

처음 게시됨 (실제)

2020년 7월 22일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2026년 9월 22일

QC 기준을 충족하는 마지막 업데이트 제출

2026년 9월 17일

마지막으로 확인됨

2026년 9월 1일

추가 정보

이 연구와 관련된 용어

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

구독하다